Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.76 is 87% above its 5-year average of 2.01, near the high end of its 5-year range (0.22–3.76).
As of the fiscal period ended Tuesday, June 30, 2026. 205.17% above its 12-month average of 1.23.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.76.
CURRENT RATIO
3.76
CURRENT RATIO AVG TTM
1.23
CURRENT RATIO AVG 3Y
1.81
CURRENT RATIO AVG 5Y
2.01
CURRENT RATIO AVG 10Y
2.77
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+205.17%
CURRENT VS 3Y AVG
+107.42%
CURRENT VS 5Y AVG
+87.44%
CURRENT VS 10Y AVG
+35.45%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+0.22%
vs the sector median at left
Market Cap
$983.83M
Current Ratio
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$991.32M
Current Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$993.61M
Current Ratio
6.55
TTM Avg
7.96
3Y Avg
7.82
5Y Avg
9.82
Market Cap
$977.87M
Current Ratio
5.04
TTM Avg
3.47
3Y Avg
3.89
5Y Avg
3.30
Market Cap
$1.01B
Current Ratio
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$962.60M
Current Ratio
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | $985.62M | 3.76 | 1.23 | 1.81 | 2.01 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $983.83M | 15.08 | 22.50 | 27.08 | 27.08 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $991.32M | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $993.61M | 6.55 | 7.96 | 7.82 | 9.82 |
| Pacira BioSciences, Inc. (PCRX)vs › | $977.87M | 5.04 | 3.47 | 3.89 | 3.30 |
| Vor Biopharma Inc. (VOR)vs › | $996.21M | 19.15 | 11.70 | 12.62 | 12.74 |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | 8.42 | 11.89 | 15.48 | 17.00 |
| Aktis Oncology, Inc. (AKTS)vs › | $962.60M | 16.33 | 11.68 | 16.13 | 16.13 |
| Savara Inc. (SVRA)vs › | $959.20M | 10.13 | 12.79 | 15.81 | 14.15 |
Current Ratio
3.76
Quick Ratio
3.76
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.76 |
| 2026-03-31 | 0.55 |
| 2025-12-31 | 0.75 |
| 2025-09-30 | 0.22 |
| 2025-06-30 | 0.88 |
| 2025-03-31 | 1.53 |
| 2024-12-31 | 2.03 |
| 2024-09-30 | 2.34 |
| 2024-06-30 | 2.36 |
| 2024-03-31 | 3.14 |
| 2023-12-31 | 2.38 |
| 2023-09-30 | 1.63 |
| 2023-06-30 | 1.99 |
| 2023-03-31 | 1.50 |
| 2022-12-31 | 1.88 |
| 2022-09-30 | 2.14 |
| 2022-06-30 | 1.55 |
| 2022-03-31 | 2.18 |
| 2021-12-31 | 2.69 |
| 2021-09-30 | 2.97 |
| 2021-06-30 | 3.62 |
| 2021-03-31 | 4.30 |
| 2020-12-31 | 5.03 |
| 2020-09-30 | 4.67 |
| 2020-06-30 | 5.03 |
| 2020-03-31 | 5.83 |
| 2019-12-31 | 5.47 |
| 2019-09-30 | 6.90 |
| 2019-06-30 | 5.22 |
| 2019-03-31 | 6.96 |
| 2018-12-31 | 4.82 |
| 2018-09-30 | 10.76 |
| 2018-06-30 | 11.84 |
| 2018-03-31 | 3.03 |
| 2017-12-31 | 0.54 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
